Streetbeat News

Products Services

BPMC

RHHBY

Genentech, a member of the Roche Group, has voluntarily withdrawn the U.S. indication of Gavreto, a drug developed in collaboration with Blueprint Medicines. The decision is not due to new safety/efficacy data for Gavreto or product safety/quality issue.

Portfolio Pulse from Charles Gross

June 30, 2023 | 10:26 am

TSLA

Vehicle graphics company Wrapmate has launched a wrap configurator for Tesla's upcoming Cybertruck, offering nearly 100 wrap options. The wraps will be made using 3M Wrap Film and will be available in satin, gloss, and matte finishes. The platform also offers personalized wrap designs. The configurator is not affiliated with Tesla. Tesla's CEO Elon Musk has confirmed that the Cybertruck delivery event is scheduled for later this year.

Portfolio Pulse from Anan Ashraf

June 30, 2023 | 10:20 am

GNFT

IPSEY

Ipsen and Genfit have announced topline data from the pivotal ELATIVE Phase 3 trial of Elafibrano for Primary Biliary Cholangitis. The trial met its primary composite endpoint, with 51% of patients achieving cholestasis response compared with 4% on placebo.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 10:18 am

PFE

VGK

The European Union is set to announce a deal with Pfizer and other vaccine manufacturers to reserve capacity for up to 325 million vaccines annually for future health emergencies, according to Reuters.

Portfolio Pulse from Charles Gross

June 30, 2023 | 9:36 am

RDW

Redwire Corporation (NYSE:RDW) is providing critical hardware for the European Space Agency's (ESA) Euclid space telescope mission. The mission aims to create the largest, most accurate 3D map of the universe ever produced.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 9:14 am

XPEV

Xpeng has launched its G6 Ultra Smart Coupe SUV in China, leading to a 6.76% increase in its premarket shares.

Portfolio Pulse from Charles Gross

June 30, 2023 | 8:51 am

UNCY

Unicycive Therapeutics has provided an update on its marketing application for lanthanum dioxycarbonate, a treatment for hyperphosphatemia in chronic kidney disease patients on dialysis. Following the update, the company's shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:30 am

RCEL

Avita Medical has submitted a premarket approval supplement to the FDA for RECELL GO, following the original PMA of its RECELL Autologous Cell Harvesting Device and subsequent PMA supplements.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:23 am

AAPL

META

Luxury customizer Caviar has unveiled a limited edition of Apple Inc.'s (NASDAQ:AAPL) Vision Pro, priced at $39,900. The release of this exclusive Caviar Apple Vision Pro is slated for the fall of 2024. The original Apple Vision Pro, priced at $3,500, was unveiled earlier this month during the Worldwide Developers Conference 2023. Meta Platforms Inc.'s (NASDAQ:META) CEO Mark Zuckerberg has previously commented on the high price of the Apple Vision Pro.

Portfolio Pulse from Ananya Gairola

June 30, 2023 | 8:19 am

RNLX

The FDA has granted De Novo marketing authorization for Renalytix's KidneyIntelX.dkd prognostic test. The test is designed to assess the risk of progressive kidney function decline in adults with diabetes and early-stage kidney disease.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 8:16 am